Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children
BF Middleton, P Fathima, TL Snelling, P Morris - EClinicalMedicine, 2022 - thelancet.com
Background Oral rotavirus vaccines have lower effectiveness in high child mortality settings.
We evaluated the impact of additional dose (s) schedules of rotavirus vaccine on vaccine …
We evaluated the impact of additional dose (s) schedules of rotavirus vaccine on vaccine …
Incidence of Rotavirus-Related hospitalizations in an Italian Southern Region from 2015 to 2021
G Di Martino, F Cedrone, M D'Addezio, C Odio… - Diseases, 2024 - mdpi.com
(1) Background: Rotavirus is one of the leading causes of severe diarrhea and dehydration
in infants and young children worldwide. The economic and social burden of rotavirus …
in infants and young children worldwide. The economic and social burden of rotavirus …
The considerable complexities of rotavirus vaccination
KH Keddy - The Lancet Infectious Diseases, 2022 - thelancet.com
Americas, 67% in the eastern Mediterranean region, and 46% in southeast Asia, including
most countries on the Indian subcontinent (Bangladesh, Bhutan, and Sri Lanka are planning …
most countries on the Indian subcontinent (Bangladesh, Bhutan, and Sri Lanka are planning …
[HTML][HTML] A Multi-Pathogen Retrospective Study in Patients Hospitalized for Acute Gastroenteritis
A Zizza, M Guido, R Sedile, M Benelli, M Nuzzo… - Diseases, 2024 - mdpi.com
Acute gastroenteritis (AGE) is a gastrointestinal tract disease often caused by consuming
food or water contaminated by bacteria, viruses, or parasites, that can lead to severe …
food or water contaminated by bacteria, viruses, or parasites, that can lead to severe …
Learning from the bone allograft tuberculosis outbreak in the USA
C Hill, D Purtill - The Lancet Infectious Diseases, 2022 - thelancet.com
Among the diverse fields of organ, cell, and tissue transplantation, the risk of infectious
disease transmission from donor to recipient is common. Mitigating this threat requires …
disease transmission from donor to recipient is common. Mitigating this threat requires …
[HTML][HTML] Co-administration with Men-B vaccine increases Rotavirus vaccination coverage: A 5-year regionwide retrospective cohort study (STORM study)
AL Vecchio, SM Scarano, R Palladino, M Del Bene… - Vaccine, 2024 - Elsevier
Abstract Introduction In Italy Rotavirus vaccination (RVV) is provided free of charge from
2018, however, the coverage is scattered and suboptimal. The narrow time frame to …
2018, however, the coverage is scattered and suboptimal. The narrow time frame to …
Nonsecretor Phenotype Is Associated With Less Risk of Rotavirus-Associated Acute Gastroenteritis in a Vaccinated Nicaraguan Birth Cohort
Y Reyes, DT St Jean, NM Bowman… - The Journal of …, 2023 - academic.oup.com
Background Histo-blood group antigens (HBGAs) have been associated with rotavirus
vaccine take; but the effect of these HBGAs on rotavirus incidence and risk remains poorly …
vaccine take; but the effect of these HBGAs on rotavirus incidence and risk remains poorly …
Efficacy of Rotavirus Vaccines
SA Plotkin, P Offit - The Pediatric Infectious Disease Journal, 2024 - journals.lww.com
Accepted for publication February 26, 2024 The authors have no funding or conflicts of
interest to disclose.* From the University of Pennsylvania, Doylestown, Pennsylvania;† …
interest to disclose.* From the University of Pennsylvania, Doylestown, Pennsylvania;† …
Letter to the Editor on Cross-Protection of RotaTeq
C Carias, S Hartwig, N Kanibir, J Matthijnssens… - The Journal of …, 2024 - jpeds.com
Ma et al estimated the effectiveness of RotaTeq™(pentavalent rotavirus vaccine, RV5),
containing human bovine reassortants G1, G2, G3, G4, and P [8], against rotavirus …
containing human bovine reassortants G1, G2, G3, G4, and P [8], against rotavirus …
Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
X Wang, DE Velasquez Portocarrero… - Human Vaccines & …, 2023 - Taylor & Francis
In a clinical trial of Bangladeshi infants who received three doses of RotaTeq (ages 6, 10,
and 14 weeks), we did a head-to-head assessment of two vaccine virus strains to measure …
and 14 weeks), we did a head-to-head assessment of two vaccine virus strains to measure …